[CABS]The BioPacific Conference 201305/11/2013 - 05/11/2013

                    The BioPacific Conference 2013

                ——organized by the Chinese-American BioPharmaceutical Society (CABS)

Date:      Saturday May 11th, 2013   
Venue:    Crowne Plaza Hotel    
               1221 Chess Dr, Foster City, CA  



The theme of the BioPacific Conference 2013 will be “Thriving in a Challenging Time” (tentative). For the first time, we will have a CABS K. Fong Award in Life Sciences ceremony. In conjunction with the one day conference, we will also be organizing a workshop on business development skills and a one-on-one business partnering platform (details to be announced).

This full-day event is expected to attract over 500-600 professionals in various disciplines in the life science communities from across the Pacific Ocean. This will be a great opportunity to not only learn about cutting-edge science and current trend in the life science industry but also network with life science professionals from both US and China.

Sessions

    • Successful Stories & Case Studies

    • Personalized Medicine, PD marker & Diagnostic

    • Drug Discovery R&D Leveraging China-US Collaboration

    • Entrepreneurship & Emerging Market

    • Panel Discussion

Speakers

Mark Sliwkowski,               Distinguished Staff Scientist, Genentech

Christopher Kirk                 VP of Research, Onyx

Charles Hart                        VP of Biology, Threshold

Jing Huang                          Director-General of China National Center for Biotechnology  Development (CNCBD), Ministry of Science & Technology (MOST) of P.R. China

Stephen Quake                     HHMI, Stanford University

Radoje Drmanac,                 CSO, Complete Genomics

Jie Zhou                               Partner, Morison-Foerster

Ruiping Dong                      Senior VP of R&D of Emerging Market, Merck

Dan Zhang                          Chairman and CEO of Fountain Medical Development Ltd

Thomas L. Irving                 Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Richard Soll                        VP, Wuxi Aptec

Corey Goodman              Partner, VenBio

Neeraj Kumar                      Economic Development Board of Singapore

Jonathan Norris                   SVB Capital's Venture Capital

 

Panelists 

Jay Tong                              M.D., AllCells, LLC, Founder, President  & CEO

Hong Tan                            Ph. D., founder & CEO of ET Healthcare, Inc.

Songzhu (Michael) An       MD, PhD,   StemRD and Curegenix, founder.

Chris Yu                              Ph. D., AnPac Bio-Medical Science Co., Ltd., founder

Richard Qun Shan               Ph. D., Quintana Biosciences, founder, President

 

Mission of this conference 

To bring scientists, executives and other biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the biotechnology/pharmaceutical world, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.